Inventor · disambiguated record
Steven P. Tanis
Also filed as: TANIS STEVEN · TANIS STEVEN P · TANIS STEVEN PAUL
39 granted patents·24 pending applications·309 citations·filing 1989–2025
98Inventor score
Top patents by PatentIndex Score
63 records- 0198US10526284B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2017·Granted Jan 7, 2020·16 cites·17 claims
- 0297US10487105B2Trinucleotide MRNA cap analogsARCTURUS THERAPEUTICS INC·Filed 2017·Granted Nov 26, 2019·19 cites·12 claims
- 0396US10961188B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Mar 30, 2021·7 cites·20 claims
- 0496US10227302B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2018·Granted Mar 12, 2019·12 cites·20 claims
- 0595US10980895B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2019·Granted Apr 20, 2021·8 cites·20 claims
- 0695US10233148B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2017·Granted Mar 19, 2019·6 cites·20 claims
- 0794US10383952B2Ionizable cationic lipid for RNA deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted Aug 20, 2019·13 cites·16 claims
- 0893US9834510B2Aromatic ionizable cationic lipidARCTURUS THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·4 cites·20 claims
- 0989US10961187B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2019·Granted Mar 30, 2021·1 cites·24 claims
- 1089US2024059649A1Substituted n-acetyl-l-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2023·Application pending·0 cites
- 1188US9012674B1Ethyl (2R)-2-acetamido-3-(4-methylbenzoylsulfanyl)propanoate and uses thereofPROMENTIS PHARM INC·Filed 2014·Granted Apr 21, 2015·7 cites·3 claims
- 1287US10112897B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2017·Granted Oct 30, 2018·4 cites·60 claims
- 1387US6686356B2Pyridoquinoxaline antiviralsUPJOHN CO·Filed 2002·Granted Feb 3, 2004·14 cites·25 claims
- 1486US9630937B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2014·Granted Apr 25, 2017·5 cites·60 claims
- 1586US7468375B2Inhibitors of the HIV integrase enzymePFIZER·Filed 2005·Granted Dec 23, 2008·12 cites·20 claims
- 1686US5245046Aα-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agentsUPJOHN CO·Filed 1989·Granted Sep 14, 1993·23 cites·10 claims
- 1785US10358414B2Substituted N-acetyl-L-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2017·Granted Jul 23, 2019·3 cites·21 claims
- 1884US6596752B1Inhibitors of α4β1 mediated cell adhesionTANABE SEIYAKU CO·Filed 2002·Granted Jul 22, 2003·15 cites·15 claims
- 1982US12290567B2Asialoglycoprotein Receptor mediated delivery of therapeutically active conjugatesARCTURUS THERAPEUTICS INC·Filed 2020·Granted May 6, 2025·1 cites·19 claims
- 2081US10968248B2Trinucleotide mRNA cap analogsC/O ARCTURUS THERAPEUTICS INC·Filed 2019·Granted Apr 6, 2021·2 cites·18 claims
- 2181US9562012B2PPAR-sparing compounds for the treatment of metabolic diseasesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Feb 7, 2017·6 cites·23 claims
- 2279US7045646B2Process to produce enantiomerically enriched alcohols and aminesAGOURON PHARMA·Filed 2004·Granted May 16, 2006·21 cites·18 claims
- 2379US6852731B2Antiviral compoundsPFIZER·Filed 2003·Granted Feb 8, 2005·15 cites·64 claims
- 2478US2021395194A1Substituted n-acetyl-l-cysteine derivatives and related compoundsPROMENTIS PHARM INC·Filed 2021·Application pending·0 cites
- 2577US6685617B1Inhibitors of α4β1 mediated cell adhesionUPJOHN CO·Filed 1999·Granted Feb 3, 2004·24 cites·9 claims
- 2676US2024299311A1Ionizable cationic lipids and lipid nanoparticlesKARMALI PRIYA PRAKASH·Filed 2024·Application pending·0 cites
- 2775US12311033B2Lipid nanoparticle formulations and compositionsCAPSTAN THERAPEUTICS INC·Filed 2024·Granted May 27, 2025·0 cites·30 claims
- 2875US9126959B2PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseasesMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Sep 8, 2015·2 cites·1 claims
- 2974US8912335B2PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseasesCOLCA GERARD R·Filed 2010·Granted Dec 16, 2014·2 cites·1 claims
- 3073US2021323914A1Ionizable cationic lipid for rna deliveryARCTURUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3172US6482849B1Inhibitors of α4β1 mediated cell adhesionTANABE SEIYAKU CO·Filed 1998·Granted Nov 19, 2002·13 cites·17 claims
- 3271US8937182B2Synthesis for thiazolidinedione compoundsZELLER JAMES R·Filed 2011·Granted Jan 20, 2015·3 cites·1 claims
- 3370US6589504B1Compounds and methods for diagnosing and treating amyloid-related conditionsUPJOHN CO·Filed 2000·Granted Jul 8, 2003·10 cites·19 claims
- 3467US2024391870A1Ionizable cationic lipids for rna deliveryARCTURUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3566US2023320995A1Ionizable cationic lipids and lipid nanoparticlesCAPSTAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3662US2025127728A1Constrained Ionizable Cationic Lipids and Lipid NanoparticlesCAPSTAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3762US2025235404A1Peg-lipids and lipid nanoparticlesCAPSTAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3861US6329545B1Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitusFiled 1999·Granted Dec 11, 2001·14 cites·3 claims
- 3961US2023295081A1Ionizable cationic lipids for rna deliveryARCTURUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4059US8946435B2Synthesis for thiazolidinedione compoundsMETABOLIC SOLUTIONS DEV CO LLC·Filed 2014·Granted Feb 3, 2015·0 cites·3 claims
- 4159US5994577AAminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitusFiled 1995·Granted Nov 30, 1999·21 cites·3 claims
- 4259US2025228966A1Lipid nanoparticle formulations and compositionsCAPSTAN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4358US2022389422A1Ionizable cationic lipids for rna deliveryARCTURUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4457US2022378702A1Peptide-lipid conjugatesARCTURUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4556US2022370624A1Lipid compositions comprising peptide-lipid conjugatesARCTURUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4654US7692014B2Inhibitors of the HIV integrase enzymePFIZER·Filed 2005·Granted Apr 6, 2010·0 cites·4 claims
- 4749US2014018542A1Novel synthesis for thiazolidinedione compoundsMETABOLIC SOLUTIONS DEV CO LLC·Filed 2013·Application pending·0 cites
- 4847US6166080AAminoquanidine carboxylates for the treatment of obesityPHARMACIA IND·Filed 1995·Granted Dec 26, 2000·6 cites·11 claims
- 4947US2002082448A1Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitusUPJOHN CO·Filed 2001·Application pending·0 cites
- 5046US9962449B2MultiLigand agent for drug deliveryARCTURUS THERAPEUTICS INC·Filed 2016·Granted May 8, 2018·0 cites·19 claims
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven P. Tanis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →